About
Regenerative Medicine
Areas of Focus
Categories
Biologics & BiopharmaceuticalTissue EngineeringBoston & New England
Team (8)
Catherine Angell Sohn
Pharm.D.
BioAxone Biosciences
team_member
Dennis Choi
MD, PhD
BioAxone Biosciences
team_member
Guy Rouleau
MD, PhD, FRCP(C), OQ
BioAxone Biosciences
team_member
Lisa McKerracher
Founder and Chief Executive Officer
BioAxone Biosciences
executivefounder
Mark F
PHD
BioAxone Biosciences
team_member
Nigel Brown
MBA, PhD
BioAxone Biosciences
team_member
Clinical Trials (15)
View allTotal Trials
15
As Lead Sponsor
12
As Collaborator
3
Total Enrollment
1,881
By Phase
PHASE1: 3PHASE4: 2PHASE3: 6PHASE2: 3PHASE2/PHASE3: 1
By Status
COMPLETED: 7ACTIVE_NOT_RECRUITING: 3RECRUITING: 2WITHDRAWN: 2UNKNOWN: 1
Clinical Trials Pipeline14 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07053852Collaborator
Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage
PHASE1Recruiting
10 participants
Started: Jun 27, 2025 · Completed: Feb 1, 2026
NCT06745999Collaborator
Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face
PHASE4Recruiting
40 participants
Started: May 3, 2023 · Completed: Jun 30, 2025
NCT05662202Lead Sponsor
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
PHASE3Active, not recruiting
172 participants
Started: Dec 12, 2022 · Completed: Jun 30, 2026
NCT05359419Collaborator
Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities
PHASE4Unknown
20 participants
Started: May 15, 2022 · Completed: Dec 30, 2023
NCT05080764Lead Sponsor
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
PHASE2Active, not recruiting
126 participants
Started: Dec 10, 2021 · Completed: Nov 30, 2025
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...